What Are Senescent Cells? The “Zombie Cells” of Aging Explained 

Your body is constantly making new cells, repairing damaged ones, and removing cells that are no longer needed.

But sometimes a cell reaches a point where it stops dividing without actually dying. It remains metabolically active, changes how it behaves, and can begin sending signals to the cells around it.

These are senescent cells.

You may have heard them called “zombie cells” because they are no longer functioning like normal cells, yet they haven't been removed. The nickname is memorable—but the biology is more interesting than the metaphor.

Cellular senescence is a protective response that helps prevent damaged cells from continuing to divide. The problem arises when senescent cells persist and accumulate with age, because they can release inflammatory signals that alter the environment around them.

Researchers are investigating whether selectively removing these cells with compounds called senolytics could become one strategy for healthier aging.

Why do senescent cells matter?

Imagine your body as a city.

Every day, buildings experience wear and tear. Some can be repaired. Some need to be demolished and rebuilt. And occasionally, a building is too damaged to keep operating safely but remains standing.

A senescent cell is somewhat like that last building.

It has stopped dividing, which can be protective. But it hasn't necessarily shut down.

Instead, it can remain metabolically active and communicate with neighboring cells.

That communication is a major reason scientists are interested in senescence.

Senescent cells can release a collection of signaling molecules, including inflammatory cytokines, chemokines, growth factors, and other substances. Scientists call this collection the senescence-associated secretory phenotype, or SASP.

The SASP is one of the most important concepts to understand when thinking about senescent cells.

A senescent cell isn't necessarily harmful simply because it exists.

The concern is what happens when senescent cells persist and their signals begin changing the tissue environment around them.

What is cellular senescence?

Let's start with the simplest definition.

Cellular senescence is a state in which a cell permanently or stably stops dividing in response to stress or damage while remaining metabolically active.

The cell cycle is the process cells use to grow and divide.

A healthy cell can move through this cycle when appropriate. A senescent cell essentially puts up a roadblock.

This can happen for several reasons, including:

• DNA damage

• Shortened or damaged telomeres

• Oxidative stress

• Certain infections

• Oncogene activation

• Other forms of cellular stress

The cell responds by stopping its division.

This is actually a useful defense mechanism.

If a cell has accumulated serious DNA damage, allowing it to continue dividing could potentially create even more problems. Senescence provides a way to stop that damaged cell from reproducing.

This is one reason senescence is not inherently bad.

It plays useful roles in development, wound healing, tissue remodeling, and protection against uncontrolled cell growth.

The problem is what happens when the response becomes chronic.

Why do cells become senescent?

Cells don't become senescent simply because they reach a certain birthday.

Instead, senescence is a response to cellular stress.

One trigger is DNA damage.

Your DNA is constantly exposed to stress from normal metabolism, environmental factors, and other sources. Cells have sophisticated repair systems, but damage can accumulate.

Another trigger is telomere shortening.

Telomeres are protective sections at the ends of chromosomes. Think of them like the plastic tips on shoelaces that help prevent the laces from fraying.

Every time certain cells divide, their telomeres become shorter.

Eventually, critically short or damaged telomeres can signal that the cell should stop dividing.

Other forms of cellular stress can also trigger senescence, including oxidative stress and mitochondrial dysfunction.

The exact pathways vary depending on the type of cell and the trigger involved.

That's an important point because senescence isn't one single biological state.

Scientists now recognize that senescent cells can differ significantly depending on the tissue they occupy, what caused them to become senescent, and what signals they release.

What makes a senescent cell different?

A senescent cell isn't simply an old cell.

That's an important distinction.

An old cell may still function normally.

A senescent cell has undergone a specific change in behavior.

It has stopped dividing and often develops other characteristic changes, including alterations in metabolism, structure, gene expression, and communication with neighboring cells.

Researchers often look for combinations of markers associated with senescence, including proteins such as p16 and p21.

But there isn't one perfect marker that identifies every senescent cell.

This makes studying senescence surprisingly difficult.

A researcher can't simply look for one molecule and say, “There is a senescent cell.”

Instead, scientists typically use multiple characteristics to identify senescence.

This complexity is one reason estimates of how many senescent cells accumulate during aging vary considerably.

What is the SASP?

Here's where senescent cells become particularly interesting.

Remember that senescent cells can remain metabolically active?

They don't simply sit quietly.

Many senescent cells begin releasing a collection of molecules that influence their surroundings.

Scientists call this the senescence-associated secretory phenotype, or SASP.

Think of the SASP as a cell's broadcast system.

A senescent cell can send chemical messages to neighboring cells, influencing inflammation, immune activity, tissue remodeling, and cellular behavior.

Some SASP components can be beneficial in the right context.

For example, temporary senescence and SASP signaling can participate in wound healing and tissue repair.

But when senescent cells persist, prolonged SASP signaling may contribute to chronic inflammation and tissue dysfunction.

This helps explain why senescent cells are increasingly discussed as one of the hallmarks of aging.

Do senescent cells increase with age?

Evidence from animal models and human tissues suggests that senescent cells accumulate with aging.

But again, the story isn't simply:

young = no senescent cells
old = lots of senescent cells

Senescence occurs throughout life.

In fact, it's important for normal biological processes.

What appears to change with aging is the balance between the creation and clearance of senescent cells.

Your immune system can recognize and remove some senescent cells.

But as we age, immune surveillance and tissue maintenance can change.

At the same time, ongoing cellular stress may generate additional senescent cells.

The result can be a gradual accumulation of cells that are no longer dividing normally but remain biologically active.

Recent research continues to investigate how senescent cells and their secreted signals relate to aging and age-associated conditions.

Why are senescent cells called “zombie cells”?

The term “zombie cells” is a metaphor—not a scientific classification.

It describes the strange behavior of senescent cells:

They aren't dividing normally, but they're not dead either.

And because some can continue releasing signaling molecules, they can influence the environment around them.

The metaphor is useful because it makes the basic concept easy to remember.

But it can also be misleading if taken too literally.

Senescent cells aren't universally harmful, and the goal of longevity research isn't to eliminate every senescent cell in the body.

Some senescent cells perform useful functions.

The scientific question is much more precise:

Can we selectively reduce the burden of harmful or persistently senescent cells while preserving the beneficial roles of temporary senescence?

That's the challenge researchers are trying to solve.

What are senolytics?

This brings us to one of the most interesting developments in longevity research.

If senescent cells can accumulate with age, could we selectively remove them?

Researchers are investigating compounds called senolytics.

The word comes from:

• senescent — referring to senescent cells

• -lytic — meaning to break down or destroy

So, simply put:

Senolytics are compounds being investigated for their ability to selectively promote the removal of senescent cells.

The idea is not to kill cells indiscriminately.

It's to exploit differences between senescent cells and healthy cells.

Senescent cells often activate survival pathways that allow them to resist normal cell death. Researchers are investigating whether certain compounds can interfere with those survival mechanisms and make senescent cells more vulnerable to removal.

This approach has produced fascinating results in animal studies.

But this is where we need to slow down.

Promising results in mice are not the same as proven benefits in humans.

What does the research on senolytics show?

Some of the most compelling evidence comes from animal research.

In several experimental models, removing senescent cells has delayed or reduced certain age-related changes and improved measures of tissue function.

These findings helped establish the idea that senescent cells aren't simply innocent bystanders of aging.

They may actively contribute to aspects of age-related decline.

Human research is now catching up—but it remains early.

One of the best-known senolytic combinations is dasatinib plus quercetin (D+Q).

Small human studies have investigated D+Q in areas including aging, physical function, and tissue health.

However, results have not been uniformly positive.

For example, a 2024 phase 2 randomized controlled trial in 60 postmenopausal women tested intermittent D+Q for effects on bone metabolism. The study did not find a significant difference in its primary measure of bone resorption at 20 weeks, although it did observe short-term changes in a bone-formation marker.

That's exactly the kind of result worth paying attention to.

It doesn't mean senolytics don't work.

It means the science is still determining which senolytics, which people, which tissues, which dosing strategies, and which outcomes matter.

That distinction separates longevity research from longevity marketing.

What is the difference between senolytics and senomorphics?

You'll sometimes see another term in longevity research: senomorphics.

The difference is fairly simple.

Senolytics aim to remove senescent cells.

Senomorphics aim to change the behavior of senescent cells without necessarily removing them.

For example, a senomorphic strategy might attempt to reduce harmful SASP signaling.

Think back to the city analogy.

A senolytic is like removing a damaged building.

A senomorphic is more like shutting down the building's disruptive communication system so it stops disturbing the neighborhood.

Both strategies are being investigated.

Neither should currently be described as a proven way to reverse human aging.

Can lifestyle affect cellular senescence?

This is an area where the science is evolving, but the answer appears to be yes.

The cellular environment matters.

Chronic metabolic stress, inflammation, oxidative stress, and other forms of cellular damage can influence pathways involved in senescence.

That doesn't mean you can completely prevent senescent cells by “living perfectly.”

You can't.

Senescence is a normal biological process.

But healthy lifestyle habits may help create an environment that supports cellular resilience and normal tissue maintenance.

Exercise

Regular physical activity is one of the strongest tools we have for healthy aging.

Exercise stimulates cellular adaptation, supports mitochondrial function, helps maintain muscle mass, and influences inflammatory and metabolic pathways.

Nutrition

A diet rich in minimally processed foods, adequate protein, fiber, fruits, vegetables, and plant compounds provides nutrients that support normal cellular metabolism and antioxidant defenses.

Metabolic health

Healthy glucose regulation and body composition matter because chronic metabolic stress can influence inflammatory and cellular stress pathways.

Sleep and recovery

Sleep supports immune regulation, metabolic health, and cellular repair processes.

The bigger lesson is this:

You don't need to find a way to eliminate every senescent cell to support healthy aging.

Your first goal is to support the systems that maintain healthy cells in the first place.

What are researchers doing about senescent cells?

The field of senotherapeutics is expanding.

Senotherapeutics is the broader category that includes strategies designed to target cellular senescence.

Researchers are investigating:

• Senolytic drugs

• Senomorphic compounds

• Immune-based approaches

• Ways to improve immune recognition of senescent cells

• Combination therapies

• Intermittent dosing strategies

• Biomarkers that can identify senescent-cell burden

One of the biggest challenges is measurement.

Scientists need better ways to determine how many senescent cells a person has, where they are located, and whether a treatment is actually removing the cells that matter.

A 2025 review highlighted the heterogeneity of senescent cells and the ongoing challenge of identifying reliable markers and developing effective senotherapeutic strategies.

This is an important reason why the field remains experimental.

We're learning not only how to target senescent cells, but also which senescent cells should be targeted.

How does PhysioGNX Senolytics fit into the picture?

Once you understand senescent cells and the idea behind senolytics, the rationale for a senolytic-focused supplement becomes easier to understand.

PhysioGNX Senolytics combines fisetin, quercetin, fenugreek, and bromelain—four compounds selected for their research interest around cellular stress, senescence-related pathways, and healthy aging.

The formula provides:

• Fisetin — a flavonoid that has attracted considerable interest for its potential senolytic activity, particularly in preclinical research.

• Quercetin — a plant flavonoid studied extensively for antioxidant, cellular signaling, and potential senolytic activity.

• Fenugreek — a botanical with a long history of nutritional and traditional use that is being investigated for its effects on metabolic and cellular pathways.

• Bromelain — a group of enzymes derived from pineapple that has been studied for its interactions with inflammatory and cellular processes.

The goal isn't to claim that these ingredients have been proven to clear senescent cells in humans.

They haven't.

Instead, the formula is built around emerging research into compounds that may interact with pathways relevant to cellular senescence and healthy aging.

Fisetin is particularly interesting because preclinical research has identified it as a compound with senolytic potential. Human evidence is still limited, including a small 2024 pilot study investigating fisetin and biological aging. Larger controlled clinical trials are needed before we can determine whether fisetin meaningfully reduces senescent-cell burden or improves healthspan in humans.

That distinction matters.

At PhysioGNX, we think it's important to separate what a compound does in a laboratory or animal model from what has been demonstrated in people.

Why is the PhysioGNX formula used intermittently?

Senolytics are an unusual category because the goal is not necessarily to provide continuous daily stimulation.

The concept being investigated is sometimes described as a “hit-and-run” approach: expose susceptible senescent cells to a senolytic intervention, allow the body to clear affected cells, and then return to normal cellular maintenance.

Clinical researchers are studying intermittent senolytic dosing for exactly this reason. The optimal schedule, however, remains an active area of research.

PhysioGNX Senolytics is designed to be taken for three consecutive days once per month, rather than as a daily supplement.

That dosing pattern reflects the intermittent approach being explored in senolytic research—not a claim that one monthly cycle has been clinically proven to “clear” senescent cells.

Can senescent cells be completely eliminated?

No—and that's not the goal.

Senescent cells serve important biological functions.

They can help stop damaged cells from dividing and participate in processes such as wound healing and tissue remodeling.

The goal of senolytic research is therefore selective targeting, not indiscriminate elimination.

Scientists are trying to understand how to reduce the accumulation of problematic senescent cells while preserving beneficial senescence.

That's a much more sophisticated goal than simply “killing zombie cells.”

Are senolytics proven to slow human aging?

Not yet.

This is one of the most important takeaways from the current research.

Animal studies provide compelling evidence that targeting senescent cells can influence aspects of aging.

Early human studies provide reasons to keep investigating the approach.

But clinical evidence is still limited, and results have been mixed.

The 2024 phase 2 D+Q trial in postmenopausal women is a good example: the primary outcome was not significantly different, even though some secondary biological changes were observed.

Meanwhile, additional human trials are underway to investigate different senolytics, populations, and health outcomes.

So the scientifically honest conclusion is:

Senolytics are one of the most promising emerging strategies in longevity research, but they are not yet proven anti-aging therapies.

The Bottom Line

Senescent cells are not simply “old cells.”

They are cells that have entered a stable state of growth arrest in response to stress or damage. This can be protective: senescence helps prevent damaged cells from continuing to divide and plays important roles in normal biology.

The problem may arise when senescent cells persist and accumulate.

Many senescent cells release a collection of signaling molecules known as the SASP, which can influence neighboring cells and contribute to a more inflammatory tissue environment.

This is why cellular senescence has become such an important area of longevity research.

Senolytics take the idea one step further.

Instead of simply trying to suppress the signals from senescent cells, senolytics are being investigated for their ability to selectively remove senescent cells.

Animal research is compelling. Human research is promising but still early.

And that distinction is worth remembering.

We don't want to eliminate every senescent cell. We want to understand which cells have become problematic, why they persist, and whether they can be selectively cleared without disrupting the useful roles of senescence.

That's the real promise of senolytic research.

If there's one thing to remember from this article, make it this:

Senescent cells are like cellular “zombies”—not because they're dead, but because they have stopped dividing while remaining biologically active. As these cells accumulate with age, their signals may influence the tissue around them. Senolytics are being studied as a way to selectively remove these cells and potentially support healthier aging.

The science is still unfolding.

And that's exactly why understanding the biology matters.

From Kelly, MS, RD

One of the reasons I joined PhysioGNX is because I believe people deserve to understand the science behind the supplements they take. My goal isn't just to tell you what an ingredient does—it's to help you understand why it matters and how it fits into healthy aging. Thanks for reading, and I'll see you in the next article.

— Kelly Harrington, MS, RD
Registered Dietitian | Nutrition Science Writer for PhysioGNX

Scientific References

1. Ajoolabady A, Pratico D, Bahijri S, et al. Hallmarks and mechanisms of cellular senescence in aging and disease. Cell Death Discovery. 2025;11:364.

2. Gorgoulis V, Adams PD, Alimonti A, et al. Cellular Senescence: Defining a Path Forward. Cell. 2019;179(4):813–827.

3. Gasek NS, Kuchel GA, Kirkland JL, Xu M. Strategies for targeting senescent cells in human disease. Nature Aging. 2022;2:870–879.

4. Gonzalez-Gualda E, Baker AG, Fruk L, Muñoz-Espín D. A guide to assessing cellular senescence in vitro and in vivo. FEBS Journal. 2021;288:56–80.

5. Gorgoulis V, Stratigi K, Leontopoulou E, et al. Cellular senescence: defining a path forward. Cell. 2019;179:813–827.

6. Gorgoulis V, et al. The senescence-associated secretory phenotype and its physiological and pathological implications. Nature Reviews Molecular Cell Biology. 2024.

7. Farr JN, Atkinson EJ, Achenbach SJ, et al. Effects of intermittent senolytic therapy on bone metabolism in postmenopausal women: a phase 2 randomized controlled trial. Nature Medicine. 2024;30:2605–2612.

8. Lee E, Burns M. The Effects of Fisetin on Reducing Biological Aging: A Pilot Study. Alternative Therapies in Health and Medicine. 2024.

9. Childs BG, Gluscevic M, Baker DJ, et al. Senescent cells: an emerging target for diseases of ageing. Nature Reviews Drug Discovery. 2017;16:718–735.

10. Kirkland JL, Tchkonia T. Senolytic drugs: from discovery to translation. Journal of Internal Medicine. 2020;288:518–536.